TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Pro Medicus Limited ( (AU:PME) ) is now available.
Pro Medicus Limited has announced an update regarding its ongoing buy-back program, detailing the acquisition of 3,865 ordinary fully paid securities on the previous day, bringing the total bought back to 23,317. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.
The most recent analyst rating on (AU:PME) stock is a Buy with a A$320.00 price target. To see the full list of analyst forecasts on Pro Medicus Limited stock, see the AU:PME Stock Forecast page.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software solutions for medical professionals. The company focuses on delivering innovative products that enhance diagnostic imaging capabilities, catering primarily to healthcare providers and institutions.
Average Trading Volume: 180,280
Technical Sentiment Signal: Buy
Current Market Cap: A$26.94B
For an in-depth examination of PME stock, go to TipRanks’ Overview page.